#160855

SARS-CoV-2 RBD fragment cell line

Cat. #160855

SARS-CoV-2 RBD fragment cell line

Cat. #: 160855

Availability: 10-12 weeks

Organism: Human

Disease: Coronavirus

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: The University of Minnesota, Twin Cities

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SARS-CoV-2 RBD fragment cell line
  • Alternate name: Recombinant SARS-CoV-2 RBD
  • Cancer type filter: Other
  • Cancers detailed: Antigen;Protein fragment;Receptor binding domain
  • Research fields: Biochemistry;Drug development;Immunology;Microbiology
  • Parental cell: HEK293F
  • Organism: Human
  • Donor: To constitutively express SARS-CoV-2 RBD, HEK293F cell line was genetically modified in the lab using the lentivirus system. More specifically, the SARS-CoV-2 RBD gene was inserted into the genome of HEK293F cells using lentiviruses, and the stably transfected cells constitutively secrete SARS-CoV-2 RBD into the cell medium at high levels. The RBD fragment has 8X his tags for subsequent purification.
  • Disease: Coronavirus
  • Description: The SAR-CoV-2 RBD fragment expressed by this cell line has been successfully used to make ELISA assays for detection of coronavirus infection in human patients.
  • Production details: To constitutively express SARS-CoV-2 RBD, HEK293F cell line was genetically modified in the lab using the lentivirus system. More specifically, the SARS-CoV-2 RBD gene was inserted into the genome of HEK293F cells using lentiviruses, and the stably transfected cells constitutively secrete SARS-CoV-2 RBD into the cell medium at high levels. The RBD fragment has 8X his tags for subsequent purification.
  • Recommended controls: No

Target Details

  • Target: Antigen, protein fragment, receptor binding domain

Handling

  • Growth medium: The cells are cultured in FreeStyle 293 Expression Medium from Thermo Fisher.

References

  • Shang et al. 2020. Nature. 581(7807):221-224. PMID: 32225175.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.